Trial Supports Hypofractionated Radiotherapy in Uterine Cancer ...Middle East

Medscape - News
A pilot study found that delivery of approximately the same dose over just 2.5 weeks, known as hypofractionation, had good short-term toxicity outcomes. MDedge News

Hence then, the article about trial supports hypofractionated radiotherapy in uterine cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Trial Supports Hypofractionated Radiotherapy in Uterine Cancer )

Apple Storegoogle play

Last updated :

Also on site :



Latest News